The formation of cytosolic DNA and the stimulation of DNA-sensing signaling with the modulation of the tumor microenvironment by midostaurin, but not its known target therapeutic effect, might be associated with the anti-PD-1-enhancing activity. Here, PDCD1 is linked to neoplasm.